Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Osteonecrosis 1Osteoarthritis, Hip 1Neoplasm Metastasis 1Infertility 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 291Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 254Paclitaxel 247Radiotherapy 230Gemcitabine 183Dexamethasone 182Biopsy 182durvalumab 168atezolizumab 150Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 132Ipilimumab 130Docetaxel 129Capecitabine 120Radiation 119Radiosurgery 113Oxaliplatin 113Pemetrexed 112Etoposide 111Fluorouracil 109venetoclax 107fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Arthroplasty, Replacement, Hip × Clear all
NCT03113981 2025-12-22

Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)

Societe ACTIVBIOMAT

Phase NA Active not recruiting
340 enrolled

Infertility, Neoplasm Metastasis, Osteonecrosis, Osteoarthritis, Hip

Data powered by HemOnc (CC BY 4.0) Colophon âš¡